102 related articles for article (PubMed ID: 17609195)
1. Antifungal use in intensive care units.
Meyer E; Schwab F; Gastmeier P; Ruden H; Heininger A
J Antimicrob Chemother; 2007 Sep; 60(3):619-24. PubMed ID: 17609195
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
[TBL] [Abstract][Full Text] [Related]
3. [Diversity in antibiotic use in intensive care units in Germany].
Meyer E; Schwab F; Schroeren-Boersch B; Rüden H; Gastmeier P
Dtsch Med Wochenschr; 2008 Feb; 133(6):235-40. PubMed ID: 18236348
[TBL] [Abstract][Full Text] [Related]
4. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.
Fondevilla E; Grau S; Mojal S; Palomar M; Matas L; Gudiol F;
Expert Rev Anti Infect Ther; 2016; 14(1):137-44. PubMed ID: 26466197
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units.
Meyer E; Schwab F; Jonas D; Rueden H; Gastmeier P; Daschner FD
Intensive Care Med; 2004 Jun; 30(6):1089-96. PubMed ID: 15045167
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic use in two cohorts of German intensive care units.
de With K; Meyer E; Steib-Bauert M; Schwab F; Daschner FD; Kern WV
J Hosp Infect; 2006 Nov; 64(3):231-7. PubMed ID: 16891039
[TBL] [Abstract][Full Text] [Related]
7. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
Moran JL; Bristow P; Solomon PJ; George C; Hart GK;
Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
[TBL] [Abstract][Full Text] [Related]
8. Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period.
Hermosilla Nájera L; Canut Blasco A; Ulibarrena Sanz M; Abasolo Osinaga E; Abecia Inchaurregui LC
Pharmacoepidemiol Drug Saf; 2003; 12(3):243-7. PubMed ID: 12733478
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of the intensive care unit admission Mortality Probability Model (MPM0-III).
Higgins TL; Kramer AA; Nathanson BH; Copes W; Stark M; Teres D
Crit Care Med; 2009 May; 37(5):1619-23. PubMed ID: 19325480
[TBL] [Abstract][Full Text] [Related]
11. Hospital use of systemic antifungal drugs.
de With K; Steib-Bauert M; Knoth H; Dörje F; Strehl E; Rothe U; Maier L; Kern WV
BMC Clin Pharmacol; 2005 Feb; 5():1. PubMed ID: 15703083
[TBL] [Abstract][Full Text] [Related]
12. Variations and determinants of antibiotic consumption in Hungarian adult intensive care units.
Benko R; Matuz M; Peto Z; Bogár L; Viola R; Doró P; Soós G; Hajdú E
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):104-9. PubMed ID: 21796720
[TBL] [Abstract][Full Text] [Related]
13. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
14. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
15. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
16. Drug usage patterns in the ICU: profile of a major metropolitan hospital and comparison with other ICUs.
Gundlach CA; Faulkner TP; Souney PF
Hosp Formul; 1991 Feb; 26(2):132-6. PubMed ID: 10109144
[TBL] [Abstract][Full Text] [Related]
17. Assessing organizational performance in intensive care units: a French experience.
Minvielle E; Aegerter P; Dervaux B; Boumendil A; Retbi A; Jars-Guincestre MC; Guidet B;
J Crit Care; 2008 Jun; 23(2):236-44. PubMed ID: 18538217
[TBL] [Abstract][Full Text] [Related]
18. Building a continuous multicenter infection surveillance system in the intensive care unit: findings from the initial data set of 9,493 patients from 71 Italian intensive care units.
Malacarne P; Langer M; Nascimben E; Moro ML; Giudici D; Lampati L; Bertolini G;
Crit Care Med; 2008 Apr; 36(4):1105-13. PubMed ID: 18379234
[TBL] [Abstract][Full Text] [Related]
19. Mortality rates under the care of junior and senior surgery residents in a surgical intensive care unit/neurologic intensive care unit: a 5-year retrospective cohort study at Taoyuan Armed Forces General Hospital.
Lee MT; Hu P; Hsi SC; Liu KY; Chao HM; Chen YQ
J Crit Care; 2008 Dec; 23(4):550-5. PubMed ID: 19056021
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II).
de With K; Bergner J; Bühner R; Dörje F; Gonnermann C; Haber M; Hartmann M; Rothe U; Strehl E; Steib-Bauert M; Kern WV
Int J Antimicrob Agents; 2004 Sep; 24(3):213-8. PubMed ID: 15325423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
